GlassScriptPhysician profile
Laura Mcintosh
NPI 1750044194
$232.79
in general payments reported to CMS, 2019-2025
9 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.86 · 2023: $18.96 · 2024: $60.37 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $40.56 | 2024-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Seqirus USA INC | $39.23 | 2024 | Flucelvax |
| Phadia US INC. | $37.21 | 2022-2023 | Immunocap |
| Pfizer INC. | $24.93 | 2025 | |
| Exact Sciences Corporation | $21.13 | 2025 | The Cologuard Plus Collection Kit |
| Biogen, INC. | $18.51 | 2025 | Zurzuvae |
| Glaxosmithkline, LLC. | $17.93 | 2025 | Shingrix, Bexsero, Arexvy |
| Organon LLC | $17.68 | 2025 | Nexplanon |
| Novo Nordisk INC | $15.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.